Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
---|
08/05/1999 | CA2319698A1 Treatment of follicular lymphomas using inhibitors of the lymphotoxin (lt) pathway |
08/05/1999 | CA2319669A1 Mutant herpes simplex viruses and uses thereof |
08/05/1999 | CA2319514A1 Spray drying of pharmaceutical formulations containing amino acid-based materials |
08/05/1999 | CA2319306A1 Peptide inhibitors of the serine protease activity associated to the ns3 protein of hcv, relevant uses and process of production |
08/05/1999 | CA2319195A1 Method of regulating glucose metabolism, and reagents related thereto |
08/05/1999 | CA2319144A1 Recombinant proteins from hgf and msp |
08/05/1999 | CA2319143A1 Modulation of sodium channels in dorsal root ganglia |
08/05/1999 | CA2319129A1 67 human secreted proteins |
08/05/1999 | CA2319117A1 Compounds for therapy and diagnosis of lung cancer and methods for their use |
08/05/1999 | CA2319081A1 Human cystatin f |
08/05/1999 | CA2318744A1 Genetic immunization with nonstructural proteins of hepatitis c virus |
08/05/1999 | CA2318513A1 Process for making absorbable microparticles |
08/05/1999 | CA2318152A1 Absorbable microparticles |
08/05/1999 | CA2317814A1 Human protein kinase molecules |
08/05/1999 | CA2316223A1 Hydrophilic coating for an intracorporeal medical device |
08/04/1999 | EP0933425A1 Semaphorin family polypeptides and polynucleotides |
08/04/1999 | EP0933424A1 Novel proteins c16 and c16n or genes encoding the same |
08/04/1999 | EP0933423A1 Meltrins |
08/04/1999 | EP0933422A1 Cyclic lipopeptide acylase |
08/04/1999 | EP0933380A1 Method of searching for physiologically active substances and process for producing the same |
08/04/1999 | EP0933379A1 Novel peptide derivatives having thiazolyl-alanine residue |
08/04/1999 | EP0933365A2 Growth hormone secretagogues |
08/04/1999 | EP0933083A1 Process for the purification of serum albumin |
08/04/1999 | EP0933082A1 Methods of manipulation of cell differentiation |
08/04/1999 | EP0932698A1 Oligonucleotide treatments and compositions for human melanoma |
08/04/1999 | EP0932689A1 Homocysteine desulphurase from the protozoan trichomonas vaginalis |
08/04/1999 | EP0932687A1 Novel human phosphorylase kinase gamma subunit |
08/04/1999 | EP0932686A2 Telomerase reverse transcriptase |
08/04/1999 | EP0932681A2 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
08/04/1999 | EP0932680A2 Compositions and methods for the prevention and diagnosis of human granulocytic ehrlichiosis |
08/04/1999 | EP0932679A1 METHODS AND COMPOSITIONS FOR DELIVERY AND EXPRESSION OF INTERFERON-$g(a) NUCLEIC ACIDS |
08/04/1999 | EP0932678A2 A family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof |
08/04/1999 | EP0932675A2 Epidermal differentiation factor |
08/04/1999 | EP0932674A1 A NOVEL MAMMALIAN GENE, bcl-w, BELONGS TO THE bcl-2 FAMILY OF APOPTOSIS-CONTROLLING GENES |
08/04/1999 | EP0932672A1 Human sulfonylurea receptor surh |
08/04/1999 | EP0932671A2 Extension of a protein-protein interaction surface to inactivate the function of a cellular protein |
08/04/1999 | EP0932668A1 Two human cathepsin proteins |
08/04/1999 | EP0932666A1 Map kinases: polypeptides, polynucleotides and uses thereof |
08/04/1999 | EP0932626A1 G protein-coupled receptor antagonists |
08/04/1999 | EP0932624A1 Pharmaceutical and diagnostic use of serum amyloid p component |
08/04/1999 | EP0932623A1 Colostrinin, and uses thereof |
08/04/1999 | EP0932621A1 An immunogenic determinant for use in the diagnosis of kaposi's sarcoma |
08/04/1999 | EP0932620A1 Antimicrobial peptide analogs of gramicidin s and compositions comprising them |
08/04/1999 | EP0932619A1 Macrocyclic peptides useful in the treatment of thrombin related disorders |
08/04/1999 | EP0932618A1 Peptide analogues containing a 7-membered lactam ring |
08/04/1999 | EP0932617A1 Inhibitors of serine proteases, particularly hepatitis c virus ns3 protease |
08/04/1999 | EP0932615A1 SELECTIVE FACTOR Xa INHIBITORS |
08/04/1999 | EP0932614A1 Peptide prodrugs containing an alpha-hydroxyacid linker |
08/04/1999 | EP0932613A1 BLOCKING EXPRESSION OF VIRULENCE FACTORS IN $i(S. AUREUS) |
08/04/1999 | EP0932608A1 SELECTIVE FACTOR Xa INHIBITORS |
08/04/1999 | EP0932606A1 Inhibitors of prenyl transferases |
08/04/1999 | EP0932598A1 ASPARTATE ESTER INHIBITORS OF INTERLEUKIN-1$g(b) CONVERTING ENZYME |
08/04/1999 | EP0932420A1 Drug delivery using terminal complement components |
08/04/1999 | EP0932418A2 Method for recombinant adeno-associated virus-directed gene therapy |
08/04/1999 | EP0932417A1 Non-antigenic toxin-conjugate and fusion protein of internalizing receptor system |
08/04/1999 | EP0932415A1 Method of preventing acute rejection following solid organ transplantation |
08/04/1999 | EP0932414A1 USES OF COMPOSITIONS WITH alpha-LACTALBUMEN BASE |
08/04/1999 | EP0932413A1 Method for treatment of immunodeficiency virus infection |
08/04/1999 | EP0932412A1 Antiviral treatment |
08/04/1999 | EP0932411A1 Compositions containing immunogenic molecules and granulocyte-macrophage colony stimulating factor, as an adjuvant |
08/04/1999 | EP0932390A1 Therapeutic liposome composition and method |
08/04/1999 | EP0871644A4 Platelet-endothelial cell adhesion molecule-1 compositions and methods |
08/04/1999 | EP0760601A4 Predicting fetal membrane rupture by mmp-9 activity |
08/04/1999 | EP0755942B1 N-amidino dermorphin derivative |
08/04/1999 | EP0744957B1 Composition and method for preventing and treating inflammation with immunoglobulin a |
08/04/1999 | EP0695309B1 Oxytocin antagonist |
08/04/1999 | EP0692970B1 Use of actin-binding compounds for the manufacture of a medicament for reducing the viscosity of pathological mucoid airway contents in the respiratory tract |
08/04/1999 | EP0665739B1 Morphogen-induced periodontal tissue regeneration |
08/04/1999 | EP0640086B1 MERCAPTOACETYLAMIDO PYRIDAZO[ 1,2-a][1,2]DIAZEPINE DERIVATIVES USEFUL AS INHIBITORS OF ENKEPHALINASE AND ACE |
08/04/1999 | EP0585242B1 Wound healing |
08/04/1999 | EP0575490B1 GnRH ANALOGS |
08/04/1999 | EP0567585B1 Hepatic growth factor receptor is the met proto-oncogene |
08/04/1999 | EP0365657B1 Dna encoding androgen receptor protein |
08/04/1999 | CN1225131A Method for treating amyotrophic lateral sclerosis |
08/04/1999 | CN1225129A Chimeric heteromultimer adhesins |
08/04/1999 | CN1225019A Inhibition of Ii synthesis |
08/04/1999 | CN1225016A Interleukin-8 as an antiviral and antitumor agent |
08/04/1999 | CN1225015A APL immunoreactive peptides, conjugates thereof and methods of treatment for aPL antibody-mediated pathologies |
08/04/1999 | CN1224718A Thiazole derivatives |
08/04/1999 | CN1044479C Process for preparation of anti-thrombin polypeptides |
08/04/1999 | CA2256942A1 Human growth hormone-containing aqueous pharmaceutical composition |
08/03/1999 | US5932779 Transgenic mouse with mutation in endogenous melanocortin-4-receptor gene; obesity, anorexia, and cachexia treatment |
08/03/1999 | US5932737 Peptide compounds for treatment of no-mediated diseases |
08/03/1999 | US5932733 Inhibitor of thrombin |
08/03/1999 | US5932716 Disclosed herein are methods and compositions for identifying morphogen analogs. |
08/03/1999 | US5932712 Annexin binding protein |
08/03/1999 | US5932706 Antibodies specific for a haemostatic protein their use for isolating protein, haemostatic compositions devoid of proteolytic cleavage products of the protein |
08/03/1999 | US5932705 Pasteurella haemolytica culturing to produce secreted polypeptides, fractionating peptides by molecular weight, identifying and purifying antigen |
08/03/1999 | US5932703 The present invention provides purified and isolated polynucleotide sequences encoding a novel human macrophage-derived c--c chemokine designated mdc, and polypeptide analogs thereof. |
08/03/1999 | US5932702 Human G-protein coupled receptor |
08/03/1999 | US5932701 ribA |
08/03/1999 | US5932700 Efficient antitumor agent; diagnostic tool for detection of uterine tumors |
08/03/1999 | US5932694 Nucleic acid molecule encoding a bifunctional protein, the protein so encoded and uses thereof |
08/03/1999 | US5932693 The present invention relates to novel antithrombotic peptides and, more particularly, to short peptides that mediate divalent cation-independent adhesion of platelets to fibronectin. |
08/03/1999 | US5932621 Methods of using ajoene for the treatment of tumors |
08/03/1999 | US5932606 Pyrazinone, pyridinone, piperidine and pyrrolidine thrombin inhibitors |
08/03/1999 | US5932567 Thrombin inhibitors |
08/03/1999 | US5932560 Treatment of conditions and disease |
08/03/1999 | US5932557 Adenosine A1 receptor antisense oligonucleotide treatment of alcohol and marijuana-induced psychomotor impairments |
08/03/1999 | US5932556 Using an oligonucleotide |